2004
DOI: 10.1016/j.jorganchem.2004.04.015
|View full text |Cite
|
Sign up to set email alerts
|

Novel titanocene anti-cancer drugs derived from fulvenes and titanium dichloride

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
38
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 89 publications
(39 citation statements)
references
References 22 publications
1
38
0
Order By: Relevance
“…In addition, alternative DNA damage-signalling pathways need to be evoked to circumvent the development of drug resistance. This observation has led to the synthesis of novel [(1,2-diaryl-1,2-dicyclopentadienyl)ethanediyl] titanium dichlorides (Tacke et al, 2004), which combine the reactivity of the titanium dichloride moiety with the ability of hydrogen bonding towards DNA of the amine ligand of cisplatin, if the aryl group is substituted accordingly. We have shown that one member from this series, Titanocene X is significantly more effective than titanium dichloride and exhibits potent cytotoxic effect on kidney carcinoma cells and is cytotoxic to cisplatin-resistant human ovarian carcinoma (Kelter et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, alternative DNA damage-signalling pathways need to be evoked to circumvent the development of drug resistance. This observation has led to the synthesis of novel [(1,2-diaryl-1,2-dicyclopentadienyl)ethanediyl] titanium dichlorides (Tacke et al, 2004), which combine the reactivity of the titanium dichloride moiety with the ability of hydrogen bonding towards DNA of the amine ligand of cisplatin, if the aryl group is substituted accordingly. We have shown that one member from this series, Titanocene X is significantly more effective than titanium dichloride and exhibits potent cytotoxic effect on kidney carcinoma cells and is cytotoxic to cisplatin-resistant human ovarian carcinoma (Kelter et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Ansa-Titanocenes are a novel series of drugs synthesised from titanium dichloride and fulvenes (Teuber et al, 1997;Hartl et al, 2001;Tacke et al, 2001b;Siddik, 2003) that contain highly substituted ethylene bridge (Tacke et al, 2001a(Tacke et al, , 2004Rehmann et al, 2005). The subsequent synthesis of unbridged titanocene analogues led to increased cytotoxicity, suggesting a promising structure -function activity of these compounds .…”
mentioning
confidence: 99%
“…The bent metallocene dichlorides can be modified either by substitution of the chloride ligands [5,6] or by substitution on the cyclopentadienyl rings [7,8]. Some of the recently prepared titanocene dichloride derivatives showed significantly better activity and stability than corresponding non-substituded counterparts [9][10][11][12]. These findings prompted us to study water-soluble vanadocene compounds [13][14][15].…”
Section: M]mentioning
confidence: 99%
“…It should also be noted that the Ti(IV) products resulting from the hydrolysis process show a strong proliferative effect in hormone-dependent breast cancers [60]. The research continues, however, using titanium complexes of particularly robust ligands [61,62]. A concurrent approach, with the aim of lowering the toxicity of these metallic drugs, is based on changing the central metal.…”
Section: 25mentioning
confidence: 99%